J&J | JNJ - Equity Capital And Reserves


J&J reported $81.19B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Abbott USD 52.06B 69M Mar/2026
Amgen USD 9.19B 532M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Baxter International USD 6.04B 86M Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Biogen USD 18.65B 394.9M Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
CONMED USD 1.02B 15.42M Mar/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.33B 10.1M Mar/2026
Eli Lilly USD 31.2B 4.66B Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Globus Medical USD 4.73B 159.06M Mar/2026
Insulet USD 1.3B 212.6M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merck USD 45.88B 6.73B Mar/2026
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Regeneron Pharmaceuticals USD 31.42B 166.7M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Stryker USD 22.42B 635M Dec/2025
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Teva Pharmaceutical Industries USD 8.23B 314M Mar/2026
Vertex Pharmaceuticals USD 19.36B 696.1M Mar/2026
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026
Zoetis USD 3.23B 98M Mar/2026